CEO SUMMARY: Many clinical lab administrators have noticed the new activism at the federal Centers for Medicare Medicaid Services (CMS) when it comes to control of establishing prices for clinical laboratory tests. In this exclusive interview, two long-time advocates for the National Independent Laboratory Association discuss several of the issues associated with the three proposed …
CMS’ Proposed Lab Rules May Not Fly with Congress Read More »
To access this post, you must purchase The Dark Report.